Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
The Big Pharma Giants Are Down
11:35am, Sunday, 06'th Nov 2022
It's evident that big pharma giant Moderna (NASDAQ: MRNA) is going through troubled times. Worse, it's dragging other big Pharma giants with it.
This Key Piece Of News Could Sparked BioNTech, Moderna — And Could Stoke Demand For Covid Boosters
12:58pm, Friday, 04'th Nov 2022
Covid vaccine stocks surged Friday after a new study suggested an added benefit of the updated omicron-targeting boosters. The post This Key Piece Of News Could Sparked BioNTech, Moderna — And Could
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
11:21am, Friday, 04'th Nov 2022
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher” immune response
BioNTech Stock Boosted on Vaccine Buzz
10:28am, Friday, 04'th Nov 2022
Stocks in China are abuzz with reopening rumors this week, leading investors to speculate on their subsequent rallies and whether or not they will be short-lived.
Pfizer, BioNTech stocks rally after announcing positive trial data on BA.4/BA.5 bivalent booster shot
07:03am, Friday, 04'th Nov 2022
Pfizer Inc. PFE, -0.21% and Germany-based partner BioNTech SE BNTX, +2.64% said new data from a Phase 2/3 trial showed that the booster for companies' omicron BA.4/BA.5-adapted bivalent COVID-19 vacci
BioNTech stock surges toward 3-month high after report China agrees to approve its COVID vaccine for foreigners
06:23am, Friday, 04'th Nov 2022
Shares of Germany-based BioNTech SE BNTX, +2.64% surged 5.1% toward a three-month high in premarket trading Friday, after The Wall Street Journal reported that China agreed to approve the biotechnolog
China Agrees to Approve BioNTech's Covid-19 Vaccine for Foreigners, German Chancellor Says
06:03am, Friday, 04'th Nov 2022
China agreed to approve BioNTech's Covid-19 vaccines for foreign residents in China, German Chancellor Olaf Scholz said in a news conference in Beijing, after he met Chinese leader Xi Jinping.
COVID: Pfizer and BioNTech study efficacy of combo COVID-flu vaccine
04:23pm, Thursday, 03'rd Nov 2022
Yahoo Finance's Anjalee Khemlani discusses Pfizer and BioNTech's study of a combination COVID and flu vaccine, plus the availability of COVID-flu tests at Quest Diagnostics.
BioNTech Shares Up On Hope For Combined Flu, Covid Shot
12:59pm, Thursday, 03'rd Nov 2022
Pfizer and BioNTech started testing a combined flu and Covid vaccine on Thursday, helping BNTX stock pare earlier Moderna-inspired losses. The post BioNTech Shares Up On Hope For Combined Flu, Covid S
Is BioNTech a Good Long-Term Buy?
06:47am, Thursday, 27'th Oct 2022
BioNTech has a burgeoning oncology portfolio up its sleeve.
BioNTech to Report Third Quarter 2022 Financial Results and Operational Update on November 7, 2022
06:45am, Monday, 24'th Oct 2022Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today?
03:05pm, Friday, 21'st Oct 2022
Stocks were set to open lower today, but the market seems to have found its groove. Everything from tech stocks to vaccine stocks are moving higher.
FDA Allows Emergency Use of Omicron-Based COVID Jabs in Kids
05:16am, Friday, 14'th Oct 2022
Anticipating a surge of COVID-19 infections later this year, the FDA broadens the label of authorized Omicron-based BA.4/BA.5 adapted bivalent boosters to include children as young as five years.
Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older
06:56am, Thursday, 13'th Oct 2022
Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data from a Phase 2/3 clinical trial of their omicron BA.4/BA.5-adapated bivalent booster showed positive result
Why Pfizer Partner BioNTech SE Shares Are Trading Higher - BioNTech (NASDAQ:BNTX)
03:26pm, Wednesday, 12'th Oct 2022
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 5.37% to $136.45 going into the close of Wednesday's trading session after the FDA granted Emergency Use Authorization to the company's 10
